Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Comment by Bullknit101on Nov 11, 2021 8:26am
295 Views
Post# 34113953

RE:Hanging on

RE:Hanging onUnfortunately, there seems to be a lot of pumping activity with these stocks. I got caught up with Hempfusion and Cardiol. Not too longer ago, Blaze Capital was interviewing the CEO and of course both touting the tremendous potential of Cardiol etc.... After everyone gets excited and stock price went up, Cardiol issues 16M shares which dilutes all existing shareholders. Of course, there's was no mention of having to raise funding. If you have the patience, you'll probably have to wait 10 years for any meaningful returns to happen with this stock or any other biotechs in the Cannabis space. CBD is everywhere and you have company like Jazz Pharma that are well funded that have the edge. I'm just not sure about the small ones like Cardiol, Tetra, Pascal, etc...I hope I'm wrong because I'm still holding - there is alot of money being lost by retail investors here.
<< Previous
Bullboard Posts
Next >>